Reviva Pharmaceuticals (RVPH) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.89
-1.3
-0.71
-0.12

Details

Expected EPS
-0.355
Actual EPS
-0.46
Surprise EPS
-0.11
Surprise Percent
-29.58%

Description

⁨Reviva Pharmaceuticals⁩ (⁦RVPH⁩) has reported earnings of ⁦-0.46⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts